TY - JOUR
T1 - Acceptability of advanced Controlled Human Infection Models: The case of a pneumococcal challenge in people living with HIV and mycobacterial challenge with Bacillus Calmette Guerin in Malawi
AU - on behalf of the Malawi Accelerated Research in Vaccines by Experimental and Laboratory Systems (MARVELS) consortium
AU - Chirwa, Anthony E.
AU - Gunda, Charity
AU - Songolo, Shalom
AU - Nsomba, Edna
AU - Toto, Neema
AU - Makhaza, Lumbani
AU - Mailboy, Mphatso
AU - Ngoliwa, Clara
AU - Chamtunga, Linda
AU - Reuben, Modesta
AU - Chakwiya, Chikondi
AU - Liwonde, Pemphero
AU - Sigoloti, Andrew
AU - Kudowa, Evaristar
AU - Tembo, Godwin
AU - Morton, Ben
AU - Galafa, Bridgette
AU - Thole, Faith
AU - Chimgoneko, Lorensio
AU - Dzonzi, Brenald
AU - Nkhoma, Vitumbiko
AU - Mangani, Edward
AU - Mayuni, Mphatso
AU - Muyaya, Alfred
AU - Kapakasa, Fanny
AU - Kamanga, Morrison P.
AU - Nthandira, Tiyamika
AU - Mwaipaya, Diana
AU - Chirwa, Nengie
AU - Banda, Ndaziona P.K.
AU - Henrion, Marc Y.R.
AU - Chikaonda, Tarsizio
AU - Jambo, Kondwani C.
AU - Kapumba, Blessings
AU - Gordon, Stephen B.
AU - Gordon, Anna C.T.
AU - Nyirenda, Deborah
AU - Alderson, Mark
AU - Antoine, Sandra
AU - Bailey, Christopher R.
AU - Bogaert, Debbie
AU - Brown, Jeremy
AU - Burr, Sarah
AU - de Jonge, Marien L.
AU - Doherty, Klara
AU - Goldblatt, David
AU - Gomes, Gabriela
AU - Gondwe, Joel
AU - Gooding, Kate
AU - Mwandumba, Henry
PY - 2026/8/18
Y1 - 2026/8/18
N2 - Controlled Human Infection Models (CHIM) in which volunteers are experimentally exposed to pathogens are used to study pathogenesis and down select among treatment and vaccine candidates. Scientifically, CHIM studies are best conducted among at-risk populations in which the infection is endemic, and who are likely to benefit from new interventions tested. Ethically, the perspectives of these communities should be carefully considered in designing such research. CHIM studies are often conducted among healthy adults, but we wished to understand study participant's and community views on conducting CHIM studies in groups other than healthy adults, particularly people living with HIV (PLHIV). We also wished to explore community perceptions of a tuberculosis CHIM (TB CHIM), initially using Bacillus Calmette Guerin (BCG) as a safe intermediate step. We conducted fourteen focus group discussions (FGD) and eight in-depth interviews (IDI) among a wide range of stakeholders including participants, health workers, community advisory groups, religious leaders and medical opinion leaders in Malawi. Discussions and interviews were recorded, transcribed and analysed using thematic and framework analysis. Four themes were described in the data, showing engaged stakeholder acceptance of CHIM studies, and confidence in the research practice and motivation. In the specific examples discussed in this work at-risk populations specifically PLHIV and complex pathogens specifically TB-CHIM, there was concern for safety, proper consent and community consultation. In addition, cultural views on gender roles in Malawi, tissue sampling and residential stays for research study were discussed. Overall, there was support for CHIM among PLHIV, and CHIM working through a BCG CHIM towards safe TB CHIM in future. Appropriate safety caveats and regulatory measures were suggested. Advice on wide, public awareness campaign methods was offered to researchers.
AB - Controlled Human Infection Models (CHIM) in which volunteers are experimentally exposed to pathogens are used to study pathogenesis and down select among treatment and vaccine candidates. Scientifically, CHIM studies are best conducted among at-risk populations in which the infection is endemic, and who are likely to benefit from new interventions tested. Ethically, the perspectives of these communities should be carefully considered in designing such research. CHIM studies are often conducted among healthy adults, but we wished to understand study participant's and community views on conducting CHIM studies in groups other than healthy adults, particularly people living with HIV (PLHIV). We also wished to explore community perceptions of a tuberculosis CHIM (TB CHIM), initially using Bacillus Calmette Guerin (BCG) as a safe intermediate step. We conducted fourteen focus group discussions (FGD) and eight in-depth interviews (IDI) among a wide range of stakeholders including participants, health workers, community advisory groups, religious leaders and medical opinion leaders in Malawi. Discussions and interviews were recorded, transcribed and analysed using thematic and framework analysis. Four themes were described in the data, showing engaged stakeholder acceptance of CHIM studies, and confidence in the research practice and motivation. In the specific examples discussed in this work at-risk populations specifically PLHIV and complex pathogens specifically TB-CHIM, there was concern for safety, proper consent and community consultation. In addition, cultural views on gender roles in Malawi, tissue sampling and residential stays for research study were discussed. Overall, there was support for CHIM among PLHIV, and CHIM working through a BCG CHIM towards safe TB CHIM in future. Appropriate safety caveats and regulatory measures were suggested. Advice on wide, public awareness campaign methods was offered to researchers.
U2 - 10.1371/journal.pgph.0006236
DO - 10.1371/journal.pgph.0006236
M3 - Article
AN - SCOPUS:105049571675
SN - 2767-3375
VL - 6
JO - PLOS Global Public Health
JF - PLOS Global Public Health
IS - 8
M1 - e0006236
ER -